Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke
Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
Hyperglycemia is common during acute ischemic stroke. However, the optimal strategy to
control hyperglycemia during acute ischemic stroke has not been established. The object of
this multicenter randomized controlled study is to determine the efficacy and safety of early
initiation of subcutaneous once-daily insulin glargine, in comparison with regular insulin,
based on a protocolized sliding scale regimen to achieve proper sugar control in acute stroke
patients with hyperglycemia admitted to the intensive care unit.
Phase:
Phase 3
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
Chang Gung Memorial Hospital Taipei Medical University Shuang Ho Hospital